Li Shao

Title: The Innovative Contributions of Li Shao in Pharmaceutical Technology

Introduction

Li Shao is a notable inventor based in Anhui, China, recognized for his contributions to pharmaceutical technology. His work primarily focuses on developing effective treatments for skin inflammatory diseases. With a patent portfolio that includes a significant innovation, Li Shao has made strides in the medical field.

Latest Patents

Li Shao holds a patent for a compound pharmaceutical composition aimed at treating skin inflammatory diseases. This innovative composition combines tofacitinib and crisaborole as active ingredients. The formulation is characterized by its stronger therapeutic effect and lower dosage, showcasing a significant synergistic therapeutic effect. This pharmaceutical composition is designed to effectively address various skin inflammatory conditions.

Career Highlights

Throughout his career, Li Shao has worked with reputable organizations, including Hefei Industrial Pharmaceutical Institute Co., Ltd and Hefei Amvite Pharmaceutical Co., Ltd. His experience in these companies has contributed to his expertise in pharmaceutical development and innovation.

Collaborations

Li Shao has collaborated with several professionals in the field, including Guangwei He and Zhaoxing Chu. These collaborations have likely enhanced his research and development efforts, leading to impactful advancements in pharmaceutical technology.

Conclusion

Li Shao's innovative work in developing a compound pharmaceutical composition for treating skin inflammatory diseases highlights his significant contributions to the field of pharmaceutical technology. His patent and collaborations reflect a commitment to improving therapeutic options for patients.